Nordicus Partners Revenue

In the fiscal year ending March 31, 2025, Nordicus Partners had annual revenue of $5.00K with 100.00% growth.

Revenue

5.00K

Revenue Growth

+100.00%

P/S Ratio

6,772.13

Revenue / Employee

n/a

Employees

n/a

Market Cap

33.86M

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	5.00K	2.50K	100.00%
Mar 31, 2024	2.50K	-	-
Mar 31, 2023	-	-	-
Mar 31, 2022	-	-	-
Dec 31, 2021	-	-	-

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Thai Airways International Public Company	5.84B
Kuber Resources	5.07M
Steel Partners Holdings L.P.	2.07B
Entrepreneur Universe Bright Group	4.86M
Siem Industries	224.73M
Paul Mueller Company	264.04M
Mestek	299.77M
Scope Industries	77.00M

Revenue Rankings

Nordicus Partners News

9 days ago - Nordicus Partners Corporation Appoints Three New Members to Its Board of Directors - GlobeNewsWire
3 months ago - Nord Anglia Education's collaboration with IMG Academy creates exciting new opportunities for student performance, leadership, and wellbeing - Benzinga
4 months ago - Bio-Convert Receives Positive Feedback from The Danish Medicine Agency (DKMA) on its Lead Drug Candidate, QR-02 for Oral Leukoplakia - GlobeNewsWire
4 months ago - Orocidin's QR-01 Shows Positive Results in Treating Periodontitis in Dogs - GlobeNewsWire
6 months ago - Orocidin and Syngene Partner to Accelerate Biotech Innovation - GlobeNewsWire
6 months ago - Orocidin QR-01 Shows a Good Safety Profile in Preclinical Toxicity Study - GlobeNewsWire
6 months ago - Bio-Convert Develops QR-02, a Potential Breakthrough in the Treatment of Oral Leukoplakia - GlobeNewsWire
7 months ago - Oricidin Launches Groundbreaking Dental Gel for Long-Term Periodontitis Treatment - GlobeNewsWire

More News